- R
R-Biopharm AG
- Heike Z.
Heike Z. has a diverse work experience in the accounting and finance field. Heike started their career as a Praktikantin at Hessischer Rechnungshof in 2015, where they gained experience in accounting. In 2016, they joined Merck Gruppe as a Werkstudentin in Finance & Controlling, and later became a Praktikantin in Brand Management. Heike continued working at Merck Gruppe until 2017. Since 2017, Heike has been working at R-Biopharm AG. Heike started as a Referentin Finanzen and then progressed to roles such as Junior Manager, Team Lead, and currently holds the position of Director Group Accounting.
Heike Z. began their education in 2013 at Hochschule Darmstadt, where they pursued a Bachelor of Science (BS) degree in BWL. Heike successfully completed their undergraduate studies in 2017.
In 2019, Heike Z. enrolled at the IU International University of Applied Sciences to pursue a Master of Arts (MA) degree in General Management. Their studies in this program lasted for three years, and they completed their degree in 2022.
In addition to their formal education, Heike Z. also participated in a non-credit online course offered by Yale University in 2020. The course, titled "Introduction to Negotiation: A Strategic Playbook for Becoming a Principled and Persuasive Negotiator," was authorized by Yale University and offered through Coursera.
Overall, Heike Z. has an education history that includes a Bachelor's degree in BWL from Hochschule Darmstadt, a Master's degree in General Management from IU International University of Applied Sciences, and an online course in negotiation offered by Yale University.
Previous companies
Org chart
Teams
This person is not in any teams
Offices
This person is not in any offices
R-Biopharm AG
R-Biopharm AG, located in Darmstadt, is one of Germany’s leading biotechnology companies. It considers itself as a pioneer for health and quality of life. The company´s aspiration is to provide the highest possible precision, safety, clarity and certainty with excellent products and solutions – in prevention, therapy and healing. Research and development at R-Biopharm has developed agile processes in order to take on new challenges to accompany a steadily growing world population into a new health era with sustainable solutions. As an internationally recognized leader, R-Biopharm stands for the development of excellent technologies, products and solutions in the fields of Clinical Diagnostics, Nutrition Care and Food and Feed Analytics. R-Biopharm is the global market leader for test systems in the field of allergen analysis. The biotechnology company is known for its products that are of high importance for human health. To this end, it unites development, production and sales under one roof and is successfully represented in more than 120 countries worldwide – through 28 subsidiaries and 120 distributors. Founded in 1988, the family-run company employs a total of around 1,300 people worldwide (690 at its headquarters in Darmstadt) and was repeatedly recognized with the “Sustainability Award” for sustainable and profitable growth. R-Biopharm is cultivating a value-oriented corporate culture and management and is family-run in the second generation. The Chairman of the Board of Directors is Christian Dreher.
